The companies were evaluated extensively on Career Pages, Job Boards, Employee Reviews & Candidate Engagement, Accolades, Recruitment Marketing, and Social Responsibility. Source: BioSpace

The company expects to only pay a tax rate of 9 percent this year, which will free up a lot of cash. Source: BioSpace

A look at three big biotech companies that have big catalysts this year that could have a, you guessed it, big effect. Source: BioSpace

The new data supports further development of SAGE-217 in disorders associated with disruption of normal sleep. Source: BioSpace

It seems that the primary news surrounding Alzheimer's disease research has been nothing but negative for years. Source: BioSpace

A look at whether the new tax reform will really spur a M&A spending spree for drugmakers. Source: BioSpace

A look at three intriguing biotech stocks that are seeing big insider buying from top-ranked insiders right now. Source: BioSpace

Rare disease giant Shire plunked down an undisclosed sum to get its hands on a preclinical autoimmune drug candidate being developed by AB Biosciences. Source: BioSpace

Since 2013, Dr. Perlmutter has served as executive vice president of Merck and president of Merck Research Laboratories. Source: BioSpace

Artelo Biosciences and the NEOMED Institute announced today that they have entered into an exclusive global option and license agreement for NEO1940. Source: BioSpace